Raul R. Rodriguez - Feb 2, 2024 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role
CEO, President, Director
Signature
/s/ Raymond Furey (Attorney-in-Fact)
Stock symbol
RIGL
Transactions as of
Feb 2, 2024
Transactions value $
-$60,082
Form type
4
Date filed
2/6/2024, 08:18 PM
Previous filing
Jan 25, 2024
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RIGL Common Stock Sale -$25.3K -22.3K -1.07% $1.13 2.07M Feb 2, 2024 Direct F1, F2
transaction RIGL Common Stock Sale -$34.8K -30.5K -1.48% $1.14 2.04M Feb 5, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.
F2 The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions ranging from $1.13 to $1.135. Upon request, the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission staff, full information regarding the shares sold at each such separate price.